Within 10 weeks, VA psilocybin trial slot counts will be publicly documented at under 200 total nationally, triggering access-gap coverage in veteran or mainstream media.

By late October 2026, public records will show that the total number of veterans who can actually enroll in VA psilocybin trials across the whole country is fewer than 200. Given that millions of veterans live with PTSD or depression, that gap is enormous — and at least one major news outlet or veteran-focused publication will write about it. This matters because it shows the distance between the political announcement and real-world access.

Government pilot trials are small by design; enrollment capacity will be far below veteran demand. This is a specific, quantitative, near-term claim (a numeric threshold plus a media-coverage trigger) that a reader could not have guessed generically.